In a small but mechanistically rich human cohort, individuals with DNMT3A-driven clonal hematopoiesis (CH) — 17 carriers versus 15 controls, all with overweight or obesity — displayed heightened trained immunity responses when monocytes were primed with β-glucan and oxidized LDL. DNMT3A mutation carriers also showed elevated CD10+ mature neutrophils, reduced neutrophil MPO release upon TLR2 stimulation, and lower baseline ex vivo cytokine production from PBMCs, suggesting a paradoxical immunological profile: blunted acute inflammatory capacity alongside an amplified epigenetic memory priming state.
Clonal hematopoiesis of indeterminate potential (CHIP), particularly DNMT3A variants, is increasingly recognized as an independent cardiovascular risk factor — roughly doubling atherosclerotic event rates in epidemiological studies. Trained immunity, whereby innate immune cells acquire epigenetic memory after an initial stimulus, is a plausible mechanistic bridge: both processes converge on IL-1β signaling and chromatin remodeling enzymes. This study is one of the first to directly link DNMT3A CHIP to quantifiable trained immunity capacity in humans, moving the field beyond association toward mechanism.
However, significant limitations temper enthusiasm. The cohort is very small (n=32), the population is restricted to older, obese individuals, and causality cannot be established from this cross-sectional design. As a preprint not yet peer-reviewed, these findings require independent replication before clinical translation. Still, the work is conceptually incremental-to-important: it offers a plausible immunological explanation for why CHIP carriers face disproportionate cardiovascular risk.